Back to Nuveen, LLC Nuveen, LLC

SLSSLS
5 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in SELLAS LIFE SCIENCES GROUP I

Yes. Nuveen Investments holds 418,729 shares of SLS (Sellas Life Sciences Group), worth $6.2M, as of its Q2 2026 13F filing. It reduced the position by 252,245 shares (-37.6%) from Q1 2026. Nuveen Investments has held SLS since Q2 2025, across 5 quarterly 13F filings.

Current Value

$6.2M

Current Shares

418,729

Total Value Change

+$4.1M

Total Shares Change

-552,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
418,729
-37.6%
$6.2M0.0%$14.76
0
2026-Q1
Decreased
670,974
-34.5%
$2.8M0.0%$4.23
0
2025-Q4
Increased
1M
+2.6%
$3.9M0.0%$3.77
27
2025-Q3
Increased
997,910
+2.7%
$1.6M0.0%$1.61
26
2025-Q2
New
971,329
-
$2.1M0.0%$2.19
36

Other major holders of SLS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used